BCN Peptides
NDC Database

BCN Peptides

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Bulk Ingredient
  • Total Records 15
  • Latest Marketing Date 2026-06-15
  • Data Source FDA
  • First Marketing Date 2012-05-28
Company Overview

Company

BCN Peptides

Country

Spain

Social Profiles

Company Snapshot

BCN Peptides

Poligon Industrial Els Vinyets-Els Fogars II 08777 Sant Quintí de Mediona, Barcelona

Spain

www.bcnpeptides.com/ info@bcnpeptides.com View on Map
NDC Records ( 15 records )
2015
28 May
Bulk Ingredient NDC: 35207-0001

Nonproprietary Name

Desmopressin acetate

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0001

Substance

DESMOPRESSIN ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2015-05-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
12 Nov
Bulk Ingredient NDC: 35207-0002

Nonproprietary Name

Octreotide

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0002

Substance

OCTREOTIDE ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2013-11-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
01 Sep
Bulk Ingredient NDC: 35207-0003

Nonproprietary Name

Salmon Calcitonin

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0003

Substance

CALCITONIN SALMON ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-09-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2012
28 May
Bulk Ingredient NDC: 35207-0004

Nonproprietary Name

Cosyntropin

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0004

Substance

COSYNTROPIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2012-05-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2012
25 Jul
Bulk Ingredient NDC: 35207-0005

Nonproprietary Name

VASOPRESSIN

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0005

Substance

VASOPRESSIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2012-07-25

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2012
31 Oct
Bulk Ingredient NDC: 35207-0006

Nonproprietary Name

CORTICOTROPIN PORCINE

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0006

Substance

CORTICOTROPIN PORCINE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2012-10-31

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
01 Sep
Bulk Ingredient NDC: 35207-0007

Nonproprietary Name

Leuprolide

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0007

Substance

LEUPROLIDE ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-09-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2014
22 Jul
Bulk Ingredient NDC: 35207-0008

Nonproprietary Name

Icatibant acetate

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0008

Substance

ICATIBANT ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2014-07-22

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
01 Sep
Bulk Ingredient NDC: 35207-0009

Nonproprietary Name

Nesiritide

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0009

Substance

NESIRITIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-09-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
01 Sep
Bulk Ingredient NDC: 35207-0010

Nonproprietary Name

Ganirelix

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0010

Substance

GANIRELIX ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-09-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
28 Aug
Bulk Ingredient NDC: 35207-0011

Nonproprietary Name

Lanreotide acetate

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0011

Substance

LANREOTIDE ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-08-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
08 Jun
Bulk Ingredient NDC: 35207-0012

Nonproprietary Name

Alarelin

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0012

Substance

ALARELIN ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-06-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
14 Mar
Bulk Ingredient NDC: 35207-0013

Nonproprietary Name

Protirelin

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN PEPTIDES SA

Marketing Category

BULK INGREDIENT

35207-0013

Substance

PROTIRELIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2024-03-14

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2026
07 Apr
Bulk Ingredient NDC: 35207-0014

Nonproprietary Name

Terlipressin

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN Peptides SA

Marketing Category

BULK INGREDIENT

35207-0014

Substance

TERLIPRESSIN ACETATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2026-04-07

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2026
15 Jun
Bulk Ingredient NDC: 35207-0015

Nonproprietary Name

Tetracosactide

Dosage Form

POWDER

Strength

1 g/g

Labeler

BCN Peptides SA

Marketing Category

BULK INGREDIENT

35207-0015

Substance

COSYNTROPIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2026-06-15

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    6 View
  • EDQM CEP
    7 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    15 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
15 total
  • Bulk Ingredient
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

35207-0001

Nonproprietary Name

Desmopressin acetate

Labeler

BCN PEPTIDES SA

Dosage Form

POWDER

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.